Trending...
- New Book, The KI of Marketing, Helps Small Businesses Grow Without Trying to Outspend Bigger Competitors
- LCC Asia Pacific Sponsors CubeSatPlus 2026 at UNSW Sydney
- Kellyn Endorses National Push to Expand Food is Medicine
PITTSBURGH, July 25, 2024 ~ PANTHERx Rare, one of the leading rare disease specialty pharmacies in the nation, has announced the appointment of Bansi Nagji as their new CEO effective August 1, 2024. Mr. Nagji, who has been serving as a member of the company's board of directors, will now take on the additional responsibility of leading PANTHERx Rare as its CEO. This change in leadership comes as Rob Snyder, the current co-founder and CEO, transitions to a full-time role as Executive Chair.
With over 25 years of experience in various leadership roles within the healthcare industry, Mr. Nagji brings a wealth of knowledge and expertise to his new position. He has a strong background in pharma services and supply chain management, healthcare technology, and digital platforms. Throughout his career, he has successfully led high-growth businesses and implemented effective strategies for organic and inorganic growth. Prior to joining PANTHERx Rare as Executive Chair in December 2023, Mr. Nagji served as President of Healthcare at GoodRx Inc., as well as Executive Vice President and Chief Strategy and Business Development Officer at McKesson Corporation. He also has extensive experience serving on the boards of private and public companies such as Change Healthcare, Deloitte, and Parata Systems.
More on The PennZone
Meanwhile, Dr. Snyder's transition to full-time Executive Chair marks a significant milestone for PANTHERx Rare since its founding in 2011. As CEO, he played a crucial role in driving the organization's growth and transformation through various clinical, operational, and business development initiatives that have continued to benefit patients. In his new role as Executive Chair, Dr. Snyder will focus on collaborating with industry partners to ensure that PANTHERx Rare maintains its reputation for providing quality patient access to essential medications.
Expressing his excitement about taking on the role of CEO at PANTHERx Rare, Mr. Nagji said that he was looking forward to leading the company through its next phase of growth. He acknowledged Dr. Snyder's leadership and the significant impact he has had on the organization since its inception. Mr. Nagji also shared his passion for building businesses that help people gain access to critical medications and expressed his eagerness to use his experience to support PANTHERx Rare's mission of helping those living with rare diseases. He also praised the company's patient-centric culture and expressed his desire to continue working closely with Dr. Snyder in his new role as Executive Chair.
More on The PennZone
Dr. Snyder, on the other hand, reflected on PANTHERx Rare's journey so far and their goal of improving every aspect of the patient experience. He expressed his excitement about dedicating his full-time focus to developing innovative access and support services for patients along their health journey. Dr. Snyder also expressed confidence in Mr. Nagji's abilities and was eager to continue working with him as PANTHERx Rare enters its next phase of growth.
These executive appointments are a testament to PANTHERx Rare's commitment to providing expert and empathetic patient care, as well as their strong leadership bench and rapidly growing team of professionals. With Mr. Nagji at the helm, supported by Dr. Snyder in his new role, PANTHERx Rare is poised for continued success in delivering quality care for those living with rare diseases.
With over 25 years of experience in various leadership roles within the healthcare industry, Mr. Nagji brings a wealth of knowledge and expertise to his new position. He has a strong background in pharma services and supply chain management, healthcare technology, and digital platforms. Throughout his career, he has successfully led high-growth businesses and implemented effective strategies for organic and inorganic growth. Prior to joining PANTHERx Rare as Executive Chair in December 2023, Mr. Nagji served as President of Healthcare at GoodRx Inc., as well as Executive Vice President and Chief Strategy and Business Development Officer at McKesson Corporation. He also has extensive experience serving on the boards of private and public companies such as Change Healthcare, Deloitte, and Parata Systems.
More on The PennZone
- ANSI BSR Upholds Appeal of AFDE Member Andrew Sulner, MSFS, JD, finding the AAFS Academy Standards Board (ASB) Violated ANSI Essential Requirements
- Prolific Press Publishes 100 Word Fiction Issue #1, the Journal's Debut Anthology
- 100 Word Fiction Releases Issue #2: Forty Stories, One Hundred Words Each
- Kentucky's Plane Crash Data Lands Far from the State's Busiest Airports
- StockResearch AI Initiates Coverage on Apple (AAPL) With New Report Examining Valuation, AI Strategy and Future Growth
Meanwhile, Dr. Snyder's transition to full-time Executive Chair marks a significant milestone for PANTHERx Rare since its founding in 2011. As CEO, he played a crucial role in driving the organization's growth and transformation through various clinical, operational, and business development initiatives that have continued to benefit patients. In his new role as Executive Chair, Dr. Snyder will focus on collaborating with industry partners to ensure that PANTHERx Rare maintains its reputation for providing quality patient access to essential medications.
Expressing his excitement about taking on the role of CEO at PANTHERx Rare, Mr. Nagji said that he was looking forward to leading the company through its next phase of growth. He acknowledged Dr. Snyder's leadership and the significant impact he has had on the organization since its inception. Mr. Nagji also shared his passion for building businesses that help people gain access to critical medications and expressed his eagerness to use his experience to support PANTHERx Rare's mission of helping those living with rare diseases. He also praised the company's patient-centric culture and expressed his desire to continue working closely with Dr. Snyder in his new role as Executive Chair.
More on The PennZone
- Netberg Announces the Aurora X2 Switch Series, Built on Xsight Labs' Programmable X2 Silicon
- Imagen Golf Named Exclusive Golf Instruction Partner at Wood Lane Golf and Social
- Pete Verbica: America Needs Statesmanship and Common Sense — Not a Cult of Personality
- Heidi G. Villari of The Villari Firm, PLLC Recognized in The Best Lawyers in America 2027 for Construction Law and Personal Injury Litigation
- When the Coroner's Report Isn't Enough: Colorado Families Turn to Private Autopsy for Closure
Dr. Snyder, on the other hand, reflected on PANTHERx Rare's journey so far and their goal of improving every aspect of the patient experience. He expressed his excitement about dedicating his full-time focus to developing innovative access and support services for patients along their health journey. Dr. Snyder also expressed confidence in Mr. Nagji's abilities and was eager to continue working with him as PANTHERx Rare enters its next phase of growth.
These executive appointments are a testament to PANTHERx Rare's commitment to providing expert and empathetic patient care, as well as their strong leadership bench and rapidly growing team of professionals. With Mr. Nagji at the helm, supported by Dr. Snyder in his new role, PANTHERx Rare is poised for continued success in delivering quality care for those living with rare diseases.
0 Comments
Latest on The PennZone
- Master Of Science, Juggernaut Of The Screen: Landon Brittain Emerges As Hollywood's Most Unlikely Leading Man
- Black Dog Venture Partners and VC Fast Pitch to Host "San Francisco Investors and Innovators" Networking Event
- Four-Time Olympian Joetta Clark Diggs to Compete at World Masters Athletics Championships in Daegu
- New Book, The KI of Marketing, Helps Small Businesses Grow Without Trying to Outspend Bigger Competitors
- The Alistair Apartments Reaches 95% Occupancy in Downtown Lancaster, PA
- Food Journal Magazine Focuses Its Los Angeles Dining Coverage Across Three Editorial Verticals
- Where Do Missouri Plane Crashes Really Happen? Not Where You'd Think
- LCC Asia Pacific Sponsors CubeSatPlus 2026 at UNSW Sydney
- Kellyn Endorses National Push to Expand Food is Medicine
- LATO AI Automates Customer Communication to Help CSide Sports Academy and BAT 24 Nation Grow
- Real Estate Syndication Attorney Tilden Moschetti Releases The Real Estate Private Equity Blueprint
- 5X Gross Margin Improvement to Beat EPS Consensus; $54.6 Million 10-Year Contract Award Puts Cybersecurity Leader on Path to a $30 Million Run Rate
- Tina Hasselbusch, Turnstone Creative Co-founder and Chief Executive Officer, Named to LVB 300
- Pittsburgh Family Law Attorneys at Pollock Begg Earn Top Honors in 2027 Best Lawyers Guide
- Independent Colbert Packaging Thrives Amid Industrywide Consolidation
- Free Commercial Glass Estimating and Code Compliance Tools Launched by Landmark Construction - The Leading Glass Company in Los Angeles
- Tallahassee Million-Dollar Home Sales Rise in 2026 as Median Selling Time More Than Doubles
- Slotozilla Reports Strong Growth in Q2 2026
- Eric Snyder, President and Chief Executive Officer of Keystone Consulting Engineers Named to LVB 300
- Philadelphia's Girls Anthem to Host The Locker Room Experience Pop-Up for Young Women